Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Re: Food Safety Solution

23 May 2007 07:02

PuriCore Plc23 May 2007 FDA Lists Sterilox Food Safety Solution for Food Contact Sterilox Solution formally recognized as safe for direct contact with food MALVERN, PENNSYLVANIA, AND STAFFORD, UK, May 23, 2007-Sterilox Food Safety, adivision of PuriCore (London Stock Exchange: PURI), today announced it receivednotification that the US Food and Drug Administration (FDA) formally listed itsSterilox Solution as an approved food contact substance. This FDA Food ContactSubstance Notification (FCN) is specific to the Sterilox System and formallyrecognizes the Sterilox hypochlorous solution for use as a food safe sanitizerto be used when re-hydrating or rinsing fresh produce including leafy greenvegetables. The Sterilox System is already used by leading US supermarket retailers toimprove the safety and freshness of produce in supermarkets. The SteriloxSolution-which mimics the natural anti-microbial hypochlorous solution producedby the human body to fight pathogens-is highly effective at killing a broadrange of pathogens and spoilage organisms including E.coli, Salmonella,Staphylococcus, Listeria, norovirus, avian influenza, yeast, and molds. "This FDA Food Contact Notification represents yet another validation of ourtechnology, and it builds on our existing EPA and other regulatory approvals forthe use of the Sterilox Solution on fresh produce," said Tom Daniel, Senior VicePresident of Sterilox Food Safety. "Pursuing a formal FCN listing alsodemonstrates that Sterilox Food Safety remains committed to leading and workingwith the food retail industry to improve the safety and freshness of produce forsupermarket chains and their customers. Food retailers rely on the SteriloxSystem as an added layer of brand protection in the stores' comprehensivefood-safety plan that starts with the grower and ends with the consumer." -MORE- About Sterilox Food Safety Sterilox Food Safety is a division of PuriCore plc. The Sterilox System usessalt, water, and electricity to generate a food-safe sanitizer on site and ondemand and is currently used in thousands of US retail supermarkets to improvethe safety and freshness of their produce, floral, and seafood categories. TheSterilox Solution kills harmful pathogens on contact to prevent crosscontamination when re-hydrating, misting, or rinsing fresh produce. It alsokills bacterial and spoilage organisms to enhance the shelf life and home lifeof fresh produce as well as reduce the labor required to maintain and clean thedisplay case. With the Sterilox System, retailers are protecting their brand,improving their image, reducing category shrink, and achieving greater customerloyalty. More information on Sterilox Food Safety can be found atwww.steriloxfresh.com. About PuriCore PuriCore (London Stock Exchange: PURI) is a life sciences company focused ondeveloping and commercializing proprietary products that safely, effectively,and naturally kill contagious pathogens. PuriCore's technology provides asolution to a broad range of markets that depend upon controlling contamination,including food safety, medical device disinfection, wound management, andhospitality. The Company's proprietary technology mimics the human body'sproduction of the natural antimicrobial hypochlorous acid, which is highlyeffective in killing bacteria, viruses, and fungal spores. Deployinghypochlorous acid solutions as soaks, sprays, mists, and in other forms,PuriCore's technology is designed to limit the spread of infectious disease,including major public health threats of M. tuberculosis, MRSA, E.coli,norovirus, avian influenza, HIV, polio virus, Helicobater pylori, andLegionella. PuriCore is headquartered in Malvern, Pennsylvania, with offices inStafford, UK. To receive additional information on PuriCore, please visit our web site atwww.puricore.com, which does not form part of this press release. ### Contacts:Jennifer Guinan Tom DanielSage Strategic Marketing Sterilox Food Safety610-410-8111 484-321-2700Jennifer@sagestrat.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Mar 20197:00 amRNSCancellation of AIM Listing
25th Mar 20194:40 pmRNSSecond Price Monitoring Extn
25th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Mar 201911:12 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Mar 201910:31 amRNSForm 8.5 (EPT/RI) Earthport Plc
18th Mar 201910:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
15th Mar 20192:35 pmRNSResult of General Meeting
15th Mar 201910:09 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
14th Mar 201911:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Mar 201910:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
12th Mar 201911:53 amRNSForm 8.3 - Realm Therapeutics PLC
12th Mar 201910:07 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
11th Mar 201910:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
8th Mar 201911:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Mar 201911:16 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Mar 20199:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Mar 20199:32 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Mar 201911:41 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
1st Mar 201910:07 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
28th Feb 201911:14 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
27th Feb 20194:58 pmRNSForm 8.3 - Realm Therapeutics
27th Feb 20194:41 pmRNSSecond Price Monitoring Extn
27th Feb 20194:36 pmRNSPrice Monitoring Extension
27th Feb 201911:01 amGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics PLC
26th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
25th Feb 201910:08 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
22nd Feb 201911:36 amGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics PLC
22nd Feb 201910:02 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Feb 20194:34 pmRNSForm 8.3 - Realm Therapeutics plc
21st Feb 20194:26 pmRNSHolding(s) in Company
21st Feb 20194:26 pmRNSHolding(s) in Company
21st Feb 201912:36 pmGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics Plc
21st Feb 20199:59 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Feb 201910:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Feb 20192:05 pmRNSSecond Price Monitoring Extn
19th Feb 20192:00 pmRNSPrice Monitoring Extension
19th Feb 20199:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Feb 20199:25 amRNSForm 8.5 (EPT/RI)Realm Therapeutics
18th Feb 20199:05 amRNSSecond Price Monitoring Extn
18th Feb 20199:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSBlock listing Interim Review
18th Feb 20197:00 amRNSUpdate on Strategic Review Re-release
15th Feb 20196:20 pmRNSUpdate on Strategic Review
15th Feb 20199:22 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
11th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Feb 20199:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Feb 201910:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Feb 20199:26 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Feb 201911:23 amRNSForm 8.5 (EPT/RI) Realm Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.